Adipokine update - New molecules, new functions

被引:16
|
作者
Gelsinger C. [1 ]
Tschoner A. [1 ]
Kaser S. [1 ]
Ebenbichler C.F. [1 ]
机构
[1] Universitätsklinik für Innere Medizin I, Department Innere Medizin, Medizinische Universität Innsbruck, 6020 Innsbruck Österreich
关键词
Adipokines; Diabetes; Inflammatory disease; Insulin resistance; Metabolic syndrome; Obesity; Visceral adipose tissue;
D O I
10.1007/s10354-010-0781-6
中图分类号
学科分类号
摘要
The prevalence of obesity is rising worldwide. Recent research findings show that adipose tissue is a highly active endocrine organ, which is involved in many physiological processes. These metabolic processes are influenced by products of the adipose tissue, so-called adipokines, which play a crucial role in the pathogenesis of the metabolic syndrome and cardiovascular disease. In addition, the two major fat depots - intraabdominal and subcutaneous - differ in their ability to secrete adipokines. In recent years the importance of the association between intraabdominal fat and the development of insulin resistance, diabetes mellitus type 2 and dyslipidemia was recognized. Therefore, accumulation of visceral adipose tissue contributes due to its ability to secrete a different pattern of adipokines to increased morbidity and mortality. This review aims to characterize novel, newly recognized adipokines and to discuss their roles in the pathogenesis of insulin resistance and atherosclerosis, as well as other metabolic complications. © Springer-Verlag 2010.
引用
收藏
页码:377 / 390
页数:13
相关论文
共 50 条
  • [21] An update on the role of irisin in the regulation of endocrine and metabolic functions
    Mahgoub, Mohamed Omer
    D'Souza, Crystal
    Al Darmaki, Reem S. M. H.
    Baniyas, May M. Y. H.
    Adeghate, Ernest
    PEPTIDES, 2018, 104 : 15 - 23
  • [22] Adipose Tissue: The New Endocrine Organ? A Review Article
    Wozniak, Susan E.
    Gee, Laura L.
    Wachtel, Mitchell S.
    Frezza, Eldo E.
    DIGESTIVE DISEASES AND SCIENCES, 2009, 54 (09) : 1847 - 1856
  • [23] A New Perspective on Metabolic Syndrome with Osteopontin: A Comprehensive Review
    Cicekli, Ipek
    Saglam, Duygu
    Takar, Nadir
    LIFE-BASEL, 2023, 13 (07):
  • [24] New and Emerging Drug Molecules Against Obesity
    George, Melvin
    Rajaram, Muthukumar
    Shanmugam, Elangovan
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS, 2014, 19 (01) : 65 - 76
  • [25] The Promising Frontier of Cardiometabolic Syndrome: A New Paradigm in Cardiology
    Khan, Ahmad R.
    Salama, Abdelaziz H.
    Aleem, Zoha
    Alfakeer, Hussein
    Alnemr, Lujain
    Shareef, Amena Maheen M.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (09)
  • [26] Testosterone in men's health: a new role for an old hormone
    Feeley, Robert J.
    Saad, Farid
    Guay, Andre
    Traish, Abdulmaged M.
    JOURNAL OF MENS HEALTH, 2009, 6 (03) : 169 - 176
  • [27] Inflammation and insulin resistance: New targets encourage new thinking
    Johnson, Andrew M. F.
    Hou, Shaocong
    Li, Pingping
    BIOESSAYS, 2017, 39 (09)
  • [28] Metabolic Syndrome in Pediatrics: Old Concepts Revised, New Concepts Discussed
    D'Adamo, Ebe
    Santoro, Nicola
    Caprio, Sonia
    PEDIATRIC CLINICS OF NORTH AMERICA, 2011, 58 (05) : 1241 - +
  • [29] Metrnl: a secreted protein with new emerging functions
    Zheng, Si-li
    Li, Zhi-yong
    Song, Jie
    Liu, Jian-min
    Miao, Chao-yu
    ACTA PHARMACOLOGICA SINICA, 2016, 37 (05) : 571 - 579
  • [30] Metabolic Syndrome in Pediatrics: Old Concepts Revised, New Concepts Discussed
    D'Adamo, Ebe
    Santoro, Nicola
    Caprio, Sonia
    ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 2009, 38 (03) : 549 - +